BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30785510)

  • 21. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
    Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP
    Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of gallstones and gallbladder disease in patients undergoing gastric bypass.
    Quesada BM; Kohan G; Roff HE; Canullán CM; Chiappetta Porras LT
    World J Gastroenterol; 2010 May; 16(17):2075-9. PubMed ID: 20440847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
    Ying J; Dai S; Fu R; Hong J; Dai C; Jin Q
    Obesity (Silver Spring); 2022 Jun; 30(6):1170-1180. PubMed ID: 35475596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
    Hossain I; Brodie J; O'Brien E; Tedman-Aucoin K; Lawlor D; Murphy R; Twells L; Pace D; Evans B; Ellsmere J
    Surg Endosc; 2023 Jul; 37(7):5236-5240. PubMed ID: 36952047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass.
    Papasavas PK; Gagné DJ; Ceppa FA; Caushaj PF
    Surg Obes Relat Dis; 2006; 2(1):41-6; discussion 46-7. PubMed ID: 16925315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
    Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
    J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholelithiasis After Sleeve Gastrectomy and Effectiveness of Ursodeoxycholic Acid Treatment.
    Şen O; Türkçapar AG; Yerdel MA
    J Laparoendosc Adv Surg Tech A; 2020 Nov; 30(11):1150-1152. PubMed ID: 32228343
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
    Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
    Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
    Magouliotis DE; Tasiopoulou VS; Svokos AA; Svokos KA; Chatedaki C; Sioka E; Zacharoulis D
    Obes Surg; 2017 Nov; 27(11):3021-3030. PubMed ID: 28889240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
    Alimoğulları M; Buluş H
    Acta Chir Belg; 2021 Apr; 121(2):109-114. PubMed ID: 33252027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials.
    Sharma A; Shanti H; Nageswaran H; Best LMJ; Patel AG
    Obes Surg; 2023 Dec; 33(12):4115-4124. PubMed ID: 37872257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial.
    Sakran N; Dar R; Assalia A; Neeman Z; Farraj M; Sherf-Dagan S; Gralnek IM; Hazzan R; Mokary SE; Nevo-Aboody H; Dola T; Kaplan U; Hershko D
    Updates Surg; 2020 Dec; 72(4):1125-1133. PubMed ID: 32666477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding.
    Moon RC; Teixeira AF; DuCoin C; Varnadore S; Jawad MA
    Surg Obes Relat Dis; 2014; 10(1):64-8. PubMed ID: 23932005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiology and Outcome of Cholelithiasis in Turkish Children.
    Baran M; Appak YC; Tumgor G; Karakoyun M; Ozdemir T; Koyluoglu G
    Indian Pediatr; 2018 Mar; 55(3):216-218. PubMed ID: 29242416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
    Wang HH; Portincasa P; de Bari O; Liu KJ; Garruti G; Neuschwander-Tetri BA; Wang DQ
    Eur J Clin Invest; 2013 Apr; 43(4):413-26. PubMed ID: 23419155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
    Fearon NM; Kearns EC; Kennedy CA; Conneely JB; Heneghan HM
    Surg Obes Relat Dis; 2022 Jan; 18(1):77-84. PubMed ID: 34772614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is routine cholecystectomy required during laparoscopic gastric bypass?
    Villegas L; Schneider B; Provost D; Chang C; Scott D; Sims T; Hill L; Hynan L; Jones D
    Obes Surg; 2004 Feb; 14(2):206-11. PubMed ID: 15018749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallbladder management in obesity surgery.
    Mason EE; Renquist KE
    Obes Surg; 2002 Apr; 12(2):222-9. PubMed ID: 11975217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choledochal cyst as an important risk factor for pediatric gallstones in low-incidence populations: A single-center review.
    Weng SC; Lee HC; Yeung CY; Chan WT; Liu HC; Jiang CB
    Pediatr Neonatol; 2020 Dec; 61(6):598-605. PubMed ID: 32773363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.